Address
Klaus-Bungert-Strasse 4
Düsseldorf, 40468
Germany
Phone
49 211 61 81 00
Website
Sector
Healthcare
Industry
Medical - Instruments & Supplies
Employees
13632
First IPO Date
June 11, 2007
| Name | Title | Pay | Year Born |
| Uwe Ferdinand Röehrhoff | Chairman of the Management Board & CEO | 1.52M | 1962 |
| Katja Schnitzler | Global Senior Vice President of People & Organization and Member of Supervisory Board | 110,000 | 1981 |
| Wolf Uwe Lehmann | Chief Financial Officer & Member of the Management Board | 1.33M | 1971 |
| Achim Schalk | Member of the Management Board | 1.35M | 1972 |
| Ueli Utzinger | Group Senior Director Marketing & Communication | 0 | N/A |
| Carolin Nadilo | Corporate Director of Investor Relations | 0 | 1986 |
| Guido Pickert | Head of Investor Relations | 0 | N/A |
| Hans-Norbert Topp | Head of Moulded Glass Business Unit | 0 | 1961 |
Gerresheimer AG, founded in 1864 and based in Düsseldorf, Germany, is a global supplier specializing in the production and sale of packaging solutions and sophisticated drug delivery systems. The company operates through three distinct divisions. Its Plastics & Devices segment provides a variety of drug administration tools, such as inhalers, insulin pen systems, prefillable syringes, and diagnostic systems, for the pharmaceutical, biotech, diagnostics, and medical technology sectors. This division also manufactures plastic containers, closures, PET bottles, eye droppers, nasal sprays, nebulizers, applicators, and related accessories for solid, liquid, and ophthalmic applications, alongside bottles for nutritional supplements. The Primary Packaging Glass division offers glass primary packaging products for the pharmaceutical and cosmetics industries, including infusion, dropper, and syrup bottles; injection vials, ampoules, and cartridges; and miniature bottles for liquid food, spices, spirits, fragrances, deodorants, skincare, and wellness products. Lastly, the Advanced Technologies division focuses on developing intelligent drug delivery systems, like micro pumps, designed to enable the self-administration of medication for conditions such as Parkinson's disease or heart failure, serving its pharmaceutical and biotech clients.